Letter to the Editor: PDF Only
Potvin, Olivier PhD*; Turcotte, Valérie BA*; Duchesne, Simon PhD*,† the CIMA-Q group
*CERVO Brain Research Centre
†Department of Radiology and Nuclear Medicine, Faculty of Medicine, Laval University, Québec City, QC, Canada
Support for the enhanced NKI-RS project is provided by the NIMH BRAINS R01MH094639-01 (PI Milham), the New York State Office of Mental Health and Research Foundation for Mental Hygiene, the Child Mind Institute (1FDN2012-1), the Center for the Developing Brain at the Child Mind Institute, as well as NIMH R01MH081218, R01MH083246, and R21MH084126, NKI Center for Advanced Brain Imaging (CABI), and the Brain Research Foundation, and the Stavros Niarchos Foundation. The Consortium pour l’identification précoce de la maladie d’Alzheimer—Québec (CIMA-Q) is financed through the Fonds de recherche du Québec—Santé/Pfizer Canada—Pfizer-FRQS Innovation Fund (#25262).
Financial support for O.P. was obtained from the Alzheimer’s Society of Canada (#13-32), the Canadian Institutes of Health Research (#117121), and the Fonds de recherche du Québec—Santé/Pfizer Canada—Pfizer-FRQS Innovation Fund (#25262). S.D. is a Research Scholar from the Fonds de recherche du Québec—Santé (#30801). V.T. declare no conflicts of interest.
Alzheimer Disease & Associated Disorders ():, June 07, 2019. | DOI: